2020

Announced the approval of the U.S. ANDA (Abbreviated New Drug Application) for our company's Desmopressin Acetate Injection.

Announced that our Hsinchu facility has passed the routine inspection for Good Manufacturing Practice (GMP) by the Ministry of Health and Welfare.

Announced the approval of Taiwan's ANDA (Abbreviated New Drug Application) for our company's Olanzapine for Injection 10 mg.

Announced receipt of the notification of the pharmaceutical foreign manufacturer accreditation certificate issued by the Ministry of Health, Labour and Welfare of Japan.

Announced the approval of the U.S. ANDA (Abbreviated New Drug Application) for our company's Desmopressin Acetate Injection.